期刊文献+

阿托伐他汀对高龄患者动脉粥样硬化的影响及安全性研究 被引量:6

Clinical efficacy and safety of atorvastatin on atherosclerosis in advanced elderly patients
原文传递
导出
摘要 目的观察长期使用阿托伐他汀对于高龄(≥80岁)患者颈动脉粥样硬化病变的影响及安全性。方法61例患者进入研究,给予阿托伐他汀(20mg/d)治疗,随访5年,治疗前后检测颈动脉彩色多普勒超声及血脂、血糖、肝肾功能及肌酸激酶等。结果56例患者完成随访,治疗前后比较,低密度脂蛋白胆固醇(LDL-C)显著降低(P〈0.05),而高密度脂蛋白胆固醇(HDL-C)显著升高(P〈O.05),空腹总胆固醇、三酰甘油、血糖、血尿素、肌酐、丙氨酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)、血清总胆红素(STB)、结合胆红素(CB)、肌酸激酶(CK)治疗前后比较,差异无统计学意义(P〉0.05)。斑块面积总和显著减少[(0.63±0.41)cm。比(1.07±0.67)cm^2,t=2.118,P〈0.053,而斑块回声积分显著增加[(2.67±0.52)分比(1.53±0.44)分,t=2.771,P〈0.05],但内一中膜厚度变化差异无统计学意义[(0.11±0.02)em比(0.12±0.02)cm,t=1.528,P〉0.053。结论阿托伐他汀可以用于高龄(≥80岁)患者,长期治疗后可使动脉粥样硬化斑块缩小而且变成稳定的斑块。 Objective To investigate the effect and safety of long-term use of atorvastatin on carotid atherosclerosis in advanced elderly patients. Methods Totally 61 elderly patients with carotid atherosclerosis were permitted into study. They were treated with atorvastatin (20 rng/d) and followed-up for five years. The carotid atherosclerosis parameter and the serum levels of TC, TG, LDL-C, HDL-C, fasting blood glucose (FBG), ALT, AST, STB, CB, Bun, Cr and creatine kinase (CK) were measured before and 5 years after treatment. Results During fellow-up, 2 patients died of severe pneumonia and 1 patient died of operation complications of intestinal obstruction, with mortality rate of 4.9%. 2 patients (3.4%) gave up treatment because of muscle-related side-effect. Data was collected in 56 patients achieving study end. There was significant decrease in LDL-C (P〈 0.05) and increase in HDL-C (P〈0.05), but there was no change in serum levels of TC, TG, FBG, ALT, AST, STB, CB, BUN, Cr and CK (P〈0.05) after 5 years. The total area of carotid atherosclerosis plaque was reduced [(0.63±0. 41)cm2 vs. (1.07±0.67)cm2 , P〈0.05] and echo of carotid atherosclerosis plaque was enhanced (2.67 ± 0.52 vs. 1.53 ± 0.44, P〈0.01), but carotid intima-media thickness(IMT) appeared no change after five years. Conclusions Atorvastatin is safe in the treatment of advanced elderly patients, it can make carotid atherosclerosis plaque smaller and stable after long-term treatment.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2012年第11期974-976,共3页 Chinese Journal of Geriatrics
关键词 抗胆固醇血症药 颈动脉疾病 动脉粥样硬化 Anti-cholesterolemic agents Carotid artery diseases Atherosclerosis
  • 相关文献

参考文献13

二级参考文献40

共引文献148

同被引文献60

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33029
  • 2他汀类药物预防缺血性卒中/短暂性脑缺血发作的专家建议[J].中华内科杂志,2007,46(1):81-83. 被引量:124
  • 3NI Chroinin D, Callaly EL, Duggan J, et al. Association between acute statin therapy, survival, and improved functional outcome after ischemic stroke: the North Dublin Population Stroke Study. Stroke, 2011,42 .. 1021-1029.
  • 4Thompson PD, Clarkson P, Karas RH. Statin- associated myopathy[J]. JAMA, 2003, 289:1681-1690.
  • 5Tisha R. Narrative review:statin-related myopathy[J]. Ann Intern Med, 2009, 150:858-868.
  • 6Herman RJ. Drug interactions and the statins[J]. CMAJ, 1999, 161:1281-1286.
  • 7Fotzenlogen D. A case of atorvastatin combined toxic myopathy and inflammatory myositis[J]. J Clin Rheumatol, 2001, 7:340-345.
  • 8Ertas FS, Ertas NM, Atmaca Y, et al. Unrecognized side effect of statin treatment:unilateral blepharoptosis[J]. Ophthal Plast Reconstr Surg, 2006, 22:222-224.
  • 9Asbach P, Paetsch I, Stawowy P, et al. Statin- associated focal myositis[J]. Int J Cardiol, 2009, 133:e33-e34.
  • 10Marusic S, Lisicic A, Horvatic I, et al. Atorvastatin- related rhabdomyolysis and acute renal failure in a genetically predisposed patient with potential drug- drug interaction[J]. Int J Clin Pharm, 2012, 34:825-827.

引证文献6

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部